课题基金 / 基金详情

Assessing the Ethics of the Dominant Business Model in the Canadian Pharmaceutical Sector; Tackling Institutional Corruption through Regulatory Reforms

Assessing the Ethics of the Dominant Business Model in the Canadian Pharmaceutical Sector; Tackling Institutional Corruption through Regulatory Reforms
评估加拿大制药行业主导商业模式的道德规范；
批准号：
255847
负责人：
Gagnon Marc-Andr
金额：
$6.13万
依托单位：
Carleton University (Ottawa)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2012
资助国家：
加拿大
项目状态：
已结题
起止时间：
2012-03-01 至 2014-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=255847&lang=en
关键词：
Business Model Cost And Prices Of Medicines Ghostmanagement Of Medical Literature Innovation Policies Investment And Profitability Off-Label Use Pharmaceutical Promotion Pharmaceutical Sector Research Ethics Therapeutic Innovation

项目摘要

项目成果

Gagnon Marc-Andr的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Is the dominant business model of core pharmaceutical companies built on ethical foundations? Is the earning capacity of drug companies in line with the improvement of public health? In the last 15 years, fewer new drugs have arrived on the market, and th
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Health Systems Renewal - Evidence for Ontario on Cost Drivers, Delivery Options, and Spending Levels
  • 批准号：
    240583
  • 项目类别：
  • 资助金额：
    $0.12万
  • 财政年份：
    2011
  • 负责人：
    Gagnon Marc-Andr
  • 依托单位：
    Carleton University (Ottawa)